Iris.ai has launched an exclusive pre-sale for its AIUR tokens
GenePlanet has announced it has closed a €10 million equity deal in exchange for a qualified minority stake with Zurich-based JF Investments
Prellis Biologics, a San Francisco-based 3D tissue printing company, announced that it has reached record speed and resolution in the quest to print human tissue with viable capillaries
Enamine, a chemical research organisation and TBD Biodiscovery, a GMP manufacturer of fine chemicals have announced a collaboration agreement to manage the transition of chemical synthesis of novel intermediates from laboratory to bulk scale under GMP standards
The Pistoia Alliance has released results of a survey that found that 72 per cent of science professionals believe their sector is lagging behind other industries in the development of AI
A new system that employs Microsoft’s Kinect peripheral to help people with Parkinson’s disease overcome debilitating walking problems has been developed by researchers at Brunel University London.
The UK Prime Minister, Theresa May, is expected to outline plans to use AI and data research to reduce cancer deaths by 22,000 by the year 2033
Elsevier has announced a strategic collaboration with PerkinElmer to integrate the companies chemistry software platforms
Agilent has announced that it will acquire Genohm, a developer of highly differentiated, on-premise and cloud-based software solutions for laboratory management
Certara, a provider of model-informed drug development and regulatory science, has announced that it has acquired Analytica Laser
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
